View in EDS HTML Full Text PDF Full Text

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.

Saved in:
Bibliographic Details
Title: A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
Authors: Gasser O; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Sharples KJ; Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Barrow C; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Williams GM; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Bauer E; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Wood CE; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Mester B; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Dzhelali M; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Caygill G; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand., Jones J; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand., Hayman CM; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand., Hinder VA; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Macapagal J; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., McCusker M; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Weinkove R; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Painter GF; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand., Brimble MA; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Findlay MP; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Dunbar PR; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand.; School of Biological Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand., Hermans IF; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand. ihermans@malaghan.org.nz.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand. ihermans@malaghan.org.nz.; School of Biological Sciences, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand. ihermans@malaghan.org.nz.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Feb; Vol. 67 (2), pp. 285-298. Date of Electronic Publication: 2017 Nov 01.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29094183
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gasser+O%22">Gasser O</searchLink>; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Sharples+KJ%22">Sharples KJ</searchLink>; Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Barrow+C%22">Barrow C</searchLink>; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Williams+GM%22">Williams GM</searchLink>; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Bauer+E%22">Bauer E</searchLink>; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Wood+CE%22">Wood CE</searchLink>; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Mester+B%22">Mester B</searchLink>; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Dzhelali+M%22">Dzhelali M</searchLink>; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Caygill+G%22">Caygill G</searchLink>; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand.<br /><searchLink fieldCode="AU" term="%22Jones+J%22">Jones J</searchLink>; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hayman+CM%22">Hayman CM</searchLink>; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hinder+VA%22">Hinder VA</searchLink>; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Macapagal+J%22">Macapagal J</searchLink>; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22McCusker+M%22">McCusker M</searchLink>; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Weinkove+R%22">Weinkove R</searchLink>; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand.<br /><searchLink fieldCode="AU" term="%22Painter+GF%22">Painter GF</searchLink>; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand.<br /><searchLink fieldCode="AU" term="%22Brimble+MA%22">Brimble MA</searchLink>; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Findlay+MP%22">Findlay MP</searchLink>; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Dunbar+PR%22">Dunbar PR</searchLink>; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand.; School of Biological Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hermans+IF%22">Hermans IF</searchLink>; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand. ihermans@malaghan.org.nz.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand. ihermans@malaghan.org.nz.; School of Biological Sciences, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand. ihermans@malaghan.org.nz.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2018 Feb; Vol. 67 (2), pp. 285-298. <i>Date of Electronic Publication: </i>2017 Nov 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29094183
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-017-2085-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 285
    Titles:
      – TitleFull: A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gasser O
      – PersonEntity:
          Name:
            NameFull: Sharples KJ
      – PersonEntity:
          Name:
            NameFull: Barrow C
      – PersonEntity:
          Name:
            NameFull: Williams GM
      – PersonEntity:
          Name:
            NameFull: Bauer E
      – PersonEntity:
          Name:
            NameFull: Wood CE
      – PersonEntity:
          Name:
            NameFull: Mester B
      – PersonEntity:
          Name:
            NameFull: Dzhelali M
      – PersonEntity:
          Name:
            NameFull: Caygill G
      – PersonEntity:
          Name:
            NameFull: Jones J
      – PersonEntity:
          Name:
            NameFull: Hayman CM
      – PersonEntity:
          Name:
            NameFull: Hinder VA
      – PersonEntity:
          Name:
            NameFull: Macapagal J
      – PersonEntity:
          Name:
            NameFull: McCusker M
      – PersonEntity:
          Name:
            NameFull: Weinkove R
      – PersonEntity:
          Name:
            NameFull: Painter GF
      – PersonEntity:
          Name:
            NameFull: Brimble MA
      – PersonEntity:
          Name:
            NameFull: Findlay MP
      – PersonEntity:
          Name:
            NameFull: Dunbar PR
      – PersonEntity:
          Name:
            NameFull: Hermans IF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2018 Feb
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1